Molecular plating for targetry: proof of concept using natGd(p,x)155Tb cross section measurements
Abstract
The production of radionuclides for nuclear medicine is crucial for advancements in both diagnosis and therapy. 155Tb stands out as a promising candidate for SPECT imaging and as counterpart of the therapeutic radionuclide 161Tb in a theranostics approach. This work focuses on the gadolinium target fabrication process via molecular plating (MP) and its uses to study the production and identification of activation products when irradiated with proton. A particular attention is devoted on the quality of the produced targets using different analytical techniques. These findings contribute to ongoing efforts to establish reliable production routes for 155Tb. Our results show good agreement with the literature and simulation data, providing new experimental data to the production of 155Tb and other co-products or impurities via the bombardment of natGd targets and the contribution of (p,x) nuclear reactions, thus validating the MP technique for cross section measurements. This paves the way to fabricate enriched lanthanides target to explore extensively the production of radio-lanthanides.
Related
- Assessment of the 49Ti(d,x) route to produce the theranostic radionuclide 47Sc based on cross-section measurements
- CRISPR/Cas-Based Molecular Diagnostics for Intestinal Parasites: From Proof-of-Concept to Point-of-Care Testing
- Double Tension Band Wiring Versus Plating for Internal Fixation of Distal Humeral Fractures
- Posterior Plating Through a Single Posterolateral Approach for a Comminuted Thurston-Holland Fragment in a Pediatric Triplane Ankle Fracture
- Palmar plating for displaced metacarpal neck fractures: A new technique
BibTeX
@article{rhoden2026molecular,
title = {{Molecular plating for targetry: proof of concept using $^nat$Gd(p,x)$^155$Tb cross section measurements}},
author = {Vanessa Rhoden and Ferid Haddad and Etienne Nigron and Arnaud Guertin and Nathalie Michel and Thomas Sounalet},
journal = {Applied Radiation and Isotopes},
year = {2026},
month = oct,
doi = {10.1016/j.apradiso.2026.112779},
url = {https://hal.science/hal-05693076v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Molecular plating for targetry: proof of concept using ^natGd(p,x)^155Tb cross section measurements
AU - Vanessa Rhoden
AU - Ferid Haddad
AU - Etienne Nigron
AU - Arnaud Guertin
AU - Nathalie Michel
AU - Thomas Sounalet
PY - 2026
DA - 2026/10/12
JO - Applied Radiation and Isotopes
DO - 10.1016/j.apradiso.2026.112779
UR - https://hal.science/hal-05693076v1
AB - The production of radionuclides for nuclear medicine is crucial for advancements in both diagnosis and therapy. 155Tb stands out as a promising candidate for SPECT imaging and as counterpart of the therapeutic radionuclide 161Tb in a theranostics approach. This work focuses on the gadolinium target fabrication process via molecular plating (MP) and its uses to study the production and identification of activation products when irradiated with proton. A particular attention is devoted on the quality of the produced targets using different analytical techniques. These findings contribute to ongoing efforts to establish reliable production routes for 155Tb. Our results show good agreement with the literature and simulation data, providing new experimental data to the production of 155Tb and other co-products or impurities via the bombardment of natGd targets and the contribution of (p,x) nuclear reactions, thus validating the MP technique for cross section measurements. This paves the way to fabricate enriched lanthanides target to explore extensively the production of radio-lanthanides.
SN - 0969-8043
SN - 1872-9800
ER -